Literature DB >> 19212418

Detergent-resistant globotriaosyl ceramide may define verotoxin/glomeruli-restricted hemolytic uremic syndrome pathology.

Fahima Khan1, François Proulx2, Clifford A Lingwood3.   

Abstract

Verotoxin binding to its receptor, globotriaosyl ceramide(Gb(3)) mediates the glomerular pathology of hemolytic uremic syndrome, but Gb(3) is expressed in both tubular and glomerular cells. Gb(3) within detergent-resistant membranes, an index of glycolipid-cholesterol enriched lipid rafts, is required for in vitro cytotoxicity. We found that verotoxin 1 and 2 binding to human adult renal glomeruli is detergent resistant, whereas the strong verotoxin binding to renal tubules is detergent sensitive. Verotoxin binding to pediatric glomeruli was detergent resistant but binding to adult glomeruli was enhanced, remarkably for some samples, by detergent extraction. Detergent-sensitive glomerular components may provide age-related protection against verotoxin glomerular binding. Mouse glomeruli remained verotoxin unreactive after detergent extraction, whereas tubular binding was lost. Cholesterol extraction induced strong verotoxin binding in poorly reactive adult glomeruli, suggesting cholesterol can mask Gb(3) in glomerular lipid rafts. Binding of the human immunodeficiency virus (HIV) adhesin, gp120 (another Gb(3) ligand) was detergent sensitive, tubule-restricted, and inhibited by verotoxin B subunit pretreatment, and may relate to HIV nephropathy. Our study shows that differential membrane Gb(3) organization in glomeruli and tubules provides a basis for the age- and glomerular-restricted pathology of hemolytic uremic syndrome.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19212418     DOI: 10.1038/ki.2009.7

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  36 in total

1.  Advances in our understanding of the pathogenesis of HIV-1 associated nephropathy in children.

Authors:  Patricio E Ray; Chien-An A Hu
Journal:  Future Virol       Date:  2011-07       Impact factor: 1.831

Review 2.  Glycosphingolipid functions.

Authors:  Clifford A Lingwood
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-07-01       Impact factor: 10.005

Review 3.  Shiga toxin pathogenesis: kidney complications and renal failure.

Authors:  Tom G Obrig; Diana Karpman
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

Review 4.  Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction.

Authors:  Carla Zoja; Simona Buelli; Marina Morigi
Journal:  Pediatr Nephrol       Date:  2010-04-28       Impact factor: 3.714

5.  PCR-based detection and molecular characterization of shiga toxin-producing Escherichia coli strains in a routine microbiology laboratory over 16 years.

Authors:  K Haugum; L T Brandal; B-A Lindstedt; A L Wester; K Bergh; J E Afset
Journal:  J Clin Microbiol       Date:  2014-06-11       Impact factor: 5.948

Review 6.  Shiga Toxin (Stx) Classification, Structure, and Function.

Authors:  Angela R Melton-Celsa
Journal:  Microbiol Spectr       Date:  2014-08

7.  Shiga-like toxins and HIV-1 'go through' glycosphingolipids and lipid rafts in renal cells.

Authors:  Patricio E Ray
Journal:  Kidney Int       Date:  2009-06       Impact factor: 10.612

Review 8.  Taking a hard look at the pathogenesis of childhood HIV-associated nephropathy.

Authors:  Patricio E Ray
Journal:  Pediatr Nephrol       Date:  2009-03-14       Impact factor: 3.714

Review 9.  Pathogenic role of inflammatory response during Shiga toxin-associated hemolytic uremic syndrome (HUS).

Authors:  Ramon Alfonso Exeni; Romina Jimena Fernandez-Brando; Adriana Patricia Santiago; Gabriela Alejandra Fiorentino; Andrea Mariana Exeni; Maria Victoria Ramos; Marina Sandra Palermo
Journal:  Pediatr Nephrol       Date:  2018-01-25       Impact factor: 3.714

10.  The ether lipid precursor hexadecylglycerol protects against Shiga toxins.

Authors:  Jonas Bergan; Tore Skotland; Anne Berit Dyve Lingelem; Roger Simm; Bjørn Spilsberg; Toril Lindbäck; Tuulia Sylvänne; Helena Simolin; Kim Ekroos; Kirsten Sandvig
Journal:  Cell Mol Life Sci       Date:  2014-04-18       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.